C. Pan

Does Glycemic Control Offer Similar Benefits Among PatientsWith Diabetes in Different Regions of theWorld? Results from the ADVANCE trial

M. Woodward, N. Poulter, S. Zoungas, 2011 .

Efficacy and safety of saxagliptin in drug‐naïve Asian patients with type 2 diabetes mellitus: a randomized controlled trial

Wenying Yang, I. Gause-Nilsson, C. Tou, 2012, Diabetes/metabolism research and reviews.

Association Between Plasma Triglycerides and HDL-Cholesterol and Microvascular Kidney Disease and Retinopathy in Type 2 Diabetes: A Global Case-Control Study in 13 Countries

F. Sacks, E. Bonora, C. Wanner, 2013 .

Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial

M. Woodward, C. Anderson, D. Grobbee, 2009, Diabetologia.

Study rationale and design of ADVANCE: Action in diabetes and vascular disease - Preterax and diamicron MR controlled evaluation

R. Collins, P. Sandercock, M. Woodward, 2001 .

Study of Once Daily Levemir (SOLVE™): insights into the timing of insulin initiation in people with poorly controlled type 2 diabetes in routine clinical practice

K. Khunti, J. Yale, T. Damci, 2012, Diabetes, obesity & metabolism.

Efficacy and safety of saxagliptin in drug‐naïve Asian patients with type 2 diabetes mellitus: a randomized controlled trial

Wenying Yang, I. Gause-Nilsson, June Zhao, 2012, Diabetes/metabolism research and reviews.